Herbal pharmaceutical composition for treatment of HIV/AIDS patients
OwnerTzu-Sheng Wuinventor
Life of this patent
Estimating the term…
Abstract
The present invention provides a pharmaceutical composition for treating patients with HIV infection. The pharmaceutical composition is in the form of an intravenous injection solution and optionally capsules. The pharmaceutical composition contains fourteen (14) ingredients, i.e., diffuse hedyotis, bistort rhizome, giant knotweed rhizome, Asiatic moonseed rhizome, baical skullcap root, bovine biliary powder, milkvetch root, barbary wolfberry fruit, sanqi, figwort root, Chinese magnoliavine fruit, turmeric root-tuber, hawthorn fruit, and Chinese angelica.
Claims18
A pharmaceutical composition for treating patients with human immunodeficiency virus (HIV) infection comprising effective amounts of a mixture of aqueous extracts obtained from:
- an entire plant of Herba Hedyotidis diffusae (diffuse hedyotis);
- a rhizome of Rhizoma Bistortae (bistort rhizome);
- a rhizome of Rhizoma Polygoni Cuspidati (giant knotweed rhizome);
- a ripe fruit of Fructus Schisandrae (Chinese magnoliavine fruit);
- a rhizome of Rhizoma Menispermi (Asiatic moonseed rhizome);
- a root of Radix Scutellariae (baical skullcap root);
- bovine biliary powder;
- a root tuber of Radix Curcumae (tumeric root-tuber);
- a ripe fruit of Fructus Crataegi (hawthorn fruit);
- a root of Radix Notoginseng (sanqi);
- a ripe fruit of Fructus Lycii (barbary wolfberry fruit);
- a root of Radix Scorphulariae (figwort root);
- a root of Radix Angelicae sinensis (Chinese angelica);
- and
- a root of Radix Astragali (milkvetch root), wherein said pharmaceutical composition does not contain Radix ginseng rubra (red ginseng).
Dependencies are inferred from the claim text.